Cite
Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: Long-term results on efficacy and limb salvage in a selected group of patients.
MLA
Cherix, Stéphane, et al. “Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Non-Resectable Soft Tissue Sarcomas: Long-Term Results on Efficacy and Limb Salvage in a Selected Group of Patients.” Journal of Surgical Oncology, vol. 98, no. 3, Sept. 2008, pp. 148–55. EBSCOhost, https://doi.org/10.1002/jso.21081.
APA
Cherix, S., Speiser, M., Matter, M., Raffoul, W., Liénard, D., Theumann, N., Mouhsine, E., Mirimanoff, R.-O., Leyvraz, S., Lejeune, F. J., & Leyvraz, P.-F. (2008). Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: Long-term results on efficacy and limb salvage in a selected group of patients. Journal of Surgical Oncology, 98(3), 148–155. https://doi.org/10.1002/jso.21081
Chicago
Cherix, Stéphane, Mélanie Speiser, Maurice Matter, Wassim Raffoul, Danièle Liénard, Nicolas Theumann, Elyazid Mouhsine, et al. 2008. “Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Non-Resectable Soft Tissue Sarcomas: Long-Term Results on Efficacy and Limb Salvage in a Selected Group of Patients.” Journal of Surgical Oncology 98 (3): 148–55. doi:10.1002/jso.21081.